Clinical Trial Update: Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a triple regimen of everolimus, gemcitabine hydrochloride, and cisplatin in adults with unresectable solid tumors refractory t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Everolimus (everolimus)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: Cholangiocarcinoma of the Gallbladder, Localized Gallbladder Cancer | Phase 1 | Status: COMPLETED